Statins may lead to a range of skeletal and muscle-related adverse effects, such as myalgia, myositis, and rhabdomyolysis, characterized by a total CPK elevation exceeding 10 times the upper limit of normal, with or without AKI [1]. The gene discussed is PIK3C2A; the disease is myositis disease.